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of people reported any kind of loss of workforce participation due to illnesses/
treatments. Average work loss productivity was significantly higher in females 
vs males (16% vs 13%, p< 0.05) and decreased with increase in age (20%, 17%, 
14%, 11% and 7% in 18-29, 30-39, 40-49, 50-64 and > 64 years old, respectively, 
p-value < 0.05). ConClusions: HRPQ has good construct and criterion validity. 
Presenteeism remains higher for paid work, while absenteeism remains higher 
for unpaid work.
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objeCtives: ASCEND is a phase 3, randomized, double-blind, placebo-controlled 
trial assessing whether natalizumab slows disability progression in secondary 
progressive multiple sclerosis (SPMS) patients. The aim of this current analysis 
was to use Rasch Measurement Theory (RMT) methods to evaluate the ABILHAND 
(56 item version), a PRO assessing manual ability, in SPMS patients, and to explore 
an optimized scoring structure based on empirical post-hoc analyses. Methods: 
Baseline blinded data from the 889 randomized patients in ASCEND were ana-
lyzed. In stage 1, RMT methods examined: scale-to-sample targeting, item fit, local 
dependency, and reliability. In stage 2, a post-hoc revision of the ABILHAND-56 
scoring structure and conceptual grouping of items was conducted and re-
evaluated using the same RMT methods. Results: Stage 1 analyses showed 
adequate scale performance: minor item misfit (2/56); minimal dependency (4 
pairs of items); good reliability (Person Separation Index = 0.93). However, there 
was ABILHAND-to-ASCEND sample mis-targeting (person location range [mean]: 
-7.31 to 1.83 [-3.62]; item location range [mean]: -5.75 to 4.27 [0.00]). In stage 2, all 
items were rescored on a dichotomous response scale (easy & difficult/impos-
sible) in an attempt to improve targeting. Also, the 56 items were re-categorized 
into two conceptually clearer manual ability sub-scales: ‘fine motor skills’ and 
‘power’. These ABILHAND-56 revisions improved targeting: ‘fine motor skills’ 
(person range [mean]: -5.39 to 5.34 [-1.75]; item range [mean]: -4.15 to 3.54 [0.00]), 
‘power’ (person range [mean]: -4.47 to 4.38 [-1.72]; item range [mean]: -4.15 to 
3.54 [0.00]). Sample measurement and item fit were consistent with the original 
ABILHAND-56. ConClusions: The ABILHAND-56 revised scoring demonstrated 
improved psychometric performance and provides an initial evidence-base for 
the enhancement of ABILHAND-56’s measurement performance in people with 
SPMS. Additional research will determine whether the two sub-scale structure 
of the revised ABILHAND-56 provides better interpretability of patient-reported 
manual ability.
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objeCtives: Patient-reported outcomes (PROs) are necessary to assess dis-
ease impacts from the patient’s perspective. In line with the Food and Drug 
Administration’s (FDA’s) guidance on PROs, the Depression and Family Functioning 
Scale (DFFS) was developed to assess the impact of major depressive disorder 
(MDD) on family functioning. Psychometric analyses were conducted to establish 
the reliability, validity, and responsiveness of the DFFS according to the FDA PRO 
guidance. Methods: Data from PERFORM, a longitudinal multicenter, prospec-
tive, 2-year observational study in the United Kingdom and Spain, were analyzed 
(NBaseline= 478; NMonth2= 433). The 15 DFFS items use a 5-point rating scale to 
assess partner and family interactions and quality of relationships; higher scores 
indicate greater (worse) impacts. Test-retest reliability (intraclass correlations), con-
struct validity (correlations and factor analysis), discriminating ability (analyses 
of variance), and responsiveness (effect size estimates) were evaluated. Results: 
Factor analyses resulted in a single factor, confirmed by highly satisfactory 
Cronbach’s alphas (0.85 at baseline, 0.89 at month 2). The DFFS demonstrated sat-
isfactory test-retest reliability (intraclass correlation= 0.75). Hypothesized correla-
tions with other measures provided evidence of convergent and divergent validity. 
For example, the correlation of the DFFS with SF-12 mental component scores was 
−0.35 (baseline) −0.49 (month 2), and with SF-12 physical component scores, −0.05 
(baseline) and −0.31 (month 2). Hypothesis tests were generally in the predicted 
direction and many were statistically significant, substantiating the discriminating 
ability of the DFFS. Effect size estimates of responsiveness were 0.44–0.84, dem-
onstrating that the items were capable of detecting change. ConClusions: The 
psychometric analyses strongly support the reliability, validity, and responsiveness 
of the DFFS and its usefulness for assessing the impacts of depression on family 
functioning. It has the potential to provide important information not traditionally 
captured in clinical practice or research and will facilitate a more comprehensive 
evaluation of treatments of MDD.
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objeCtives: We systematically investigate random utility maximization and 
random regret minimization modeling approaches to establish the impact of dif-
objeCtives: Hemophilia is a chronic disease typically diagnosed in infancy, char-
acterized by bleeding requiring regular or episodic infusion of clotting factor. Taking 
care of a child with hemophilia (CWH) may cause burden for caregivers. We aimed 
to develop a first “Hemophilia associated Caregiver Burden Scale” (HEMOCABTM) 
assessing the burden of hemophilia for caregivers of CWH. Methods: 
Questionnaire development included: 1) item generation (two semi-structured 
focus groups with 11 caregivers, evaluation of existing caregiver burden scales for 
relevance by 16 HCPs); 2) feasibility testing (cognitive interviews with 12 caregivers) 
and 3) pilot-testing (psychometric analysis of HEMOCABTM). Results: Item gen-
eration resulted in a preliminary version of HEMOCABTM consisting of 109 items. 
During feasibility testing, mean completion time was 19.3±6.3 minutes, some prob-
lems were revealed concerning item formulation, applicability of items for young 
children and missing items. The revised HEMOCABTM contained 108 questions 
grouped in 13 domains. HEMOCABTM was pilot-tested in 40 caregivers of CWH 
with a mean age of 39.32±8.9. The majority of CWH had hemophilia A (95%), were 
severely affected by hemophilia (77.5%) and 15% had inhibitors. Reliability estima-
tion showed high internal consistency of total score with Cronbach’s α = .97, and 
for 2 summary scores ‘FREQUENCY’ with α = .95 and ‘BURDEN’ α = .92; Cronbach’s α 
for the sub domains ranged from α = .77 to .93. HEMOCABTM revealed good conver-
gent validity with Impact on Family Scale (r= -.867 for total score). Known groups 
validity showed significant differences in all domains of HEMOCABTM, except for 
‘school’ among caregivers of CWH with inhibitors vs. without. Type of treatment 
and disease severity showed some differences between groups. Based on item and 
scale analysis 49 items were deleted and the final HEMOCABTM consists of 59 
items. ConClusions: HEMOCABTM is the first hemophilia-specific instrument for 
the assessment of caregiver burden and revealed good psychometric characteristics 
in terms of reliability and validity.
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objeCtives: Symptoms and physical limitations can have an important impact on 
the day to day lives of heart failure patients. The Clinical Summary Score (CSS) of 
the Kansas City Cardiomyopathy Questionnaire (KCCQ), a patient-reported outcome 
instrument, provides a measure of symptoms and physical limitations associated 
with heart failure. The primary goal of this study was to evaluate the psychometric 
properties of the CSS and its utility as an endpoint in clinical trials. Methods: 
Data from 3 randomized, controlled clinical trials with heart failure patients were 
included in analysis (ALOFT, PARAMOUNT, and PARADIGM trials). Studies were 
examined independently; within each study, data were collapsed across treat-
ment groups. Study measures included the KCCQ, physician-rated New York Heart 
Association (NYHA) classification, patient global impression of change (PGIC), and/
or NT-proBNP assay. Results: Findings were similar across the 3 trials. Mean CSS 
scores at baseline ranged from 63-76 (on a 0-100 scale, with higher scores indi-
cating better symptoms and physical functioning). Dimensionality assessments 
highlighted the complex nature of the scale, with evidence for first-, second-, and 
third-order factors. The CSS consistently discriminated between all four NYHA clas-
sifications (all pairwise comparisons p< .05). Correlations with BNP and NT-proBNP 
levels were statistically significant, but relatively small (-.12 and -.17 respectively). 
The CSS was sensitive to changes in patient status over time, as indexed by changes 
in the NYHA classification and PGIC. The responder definition – the amount of 
change within an individual patient that would be considered clinically meaning-
ful - was in the range of 6 to 10 points, which is higher than what has been seen in 
studies of the KCCQ overall score. ConClusions: Data from multiple heart failure 
clinical trials confirm the psychometric characteristics of the CSS. This evidence 
supports the use of the CSS as an endpoint in clinical trials examining heart failure 
treatments.
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objeCtives: To validate the Health-Related Productivity Questionnaire (HRPQ), 
a new health-related productivity instrument, and estimate the US population 
norms by age and gender. Methods: An online survey was developed that con-
sisted of four components: the HRPQ; a screener to determine relevant disease 
conditions-related and health-state questions; validated instruments such as 
Work Productivity and Activity Impairment (WPAI) and EQ-5D; and socio-demo-
graphic questions. The survey was administered by a third-party company for 
a 6-week period. Weightings were calculated to allow extrapolation of results 
from the 10,000 respondents to achieve values representing the general United 
States population. Validation analysis included concurrent and criterion validity, 
construct validity with group difference, extreme group comparison and factor 
analysis. Mean, median, standard error, 25th and 75thpercentiles were calculated 
for absenteeism, presenteeism measures for employed and household work and 
stratified by age, gender, age and gender. Results: The HRPQ showed strong 
concurrent validity with WPAI (Pearson’s r≥ 0.6, p-value< 0.05). Correlations of total 
productivity at work and home from HRPQ with EQ-5D scores, were small to mod-
erate, r= 0.3-0.5 (p-value< 0.05) and aligned with direction of the hypothesis. Several 
group difference analyses showed positive results for HRPQ. Presenteeism items 
heavily loaded on one factor and absenteeism and scheduled hours items loaded 
on second factor. General population estimates for average percent lost produc-
tivity at work was 14%, (absenteeism= 4%, presenteeism= 10%) and for household 
activities was 28% (absenteeism= 18%, presenteeism= 10%). Furthermore, 17% 
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objeCtives: Patients’ experience of MF/SS-CTCL remains understudied due to the 
rarity of the condition. Therefore, PatientsLikeMe (PLM) aimed to harness its internal 
platform, Open Research Exchange (ORE), to explore a novel method of data collec-
tion for the concept elicitation phase of PRO development. Methods: Members 
of the MF/SS-CTCL community on PLM were invited to complete an online survey 
to share their experiences as patients. The 11 open-ended questions intended to 
elicit descriptions of MF/SS-CTCL quality of life impact, ability to cope and manage 
their condition, perception of symptoms and treatments, and sources of distress 
were administered to 21 patients. Of those, 10 participated in a follow-up interview. 
The data was analyzed by two trained raters and inter-rater reliability was used 
to validate and confirm their agreement. Results: The sample (N= 21) was pre-
dominantly female (67%), all white, and mostly reported MF (76%) rather than SS. 
The two raters achieved moderate to high inter-rater agreement for the qualitative 
analysis (0.68-0.80 Cohen’s kappa for the 43 validated codes). Saturation for the 
sample was reached after 15 patients. Dominant themes that were elicited from the 
data were social impact (f= 27), emotional impact (f= 30), impact on daily activities 
(f= 20), coping/management (f= 64), severity and burden of symptoms and treat-
ments (f= 377, f= 291), and overall treatment satisfaction (f= 291). ConClusions: 
The online method proved to be an effective tool for understanding the experiences 
of a population living with a rare condition and complimented the interview data in 
eliciting dominant themes that were present in the literature. Utilizing ORE as the 
primary method of data collection, recruitment for this rare condition was found 
to be easier and faster than traditional methods and the sample size recruited was 
validated by concept saturation. Therefore, together, the survey and the follow-up 
interviews proved to be successful in eliciting relevant concepts from patients.
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objeCtives: To develop a patient-reported outcome (PRO) instrument that assesses 
important and relevant signs, symptoms, and impacts for adult patients with pan-
creatic cancer; and to evaluate patient comprehension and usability of the draft 
Pancreatic Cancer Symptom Assessment Form (PC-SAF) administered via electronic 
diary. Methods: Concept elicitation (CE) interviews were conducted with 18 adult 
patients with pancreatic cancer from one of six US clinic sites to identify the most 
important and relevant signs, symptoms, and impacts of pancreatic cancer. Results 
from patient interviews, clinical expert interviews, and a targeted concept litera-
ture review informed the development of the draft PC-SAF, which was evaluated 
in cognitive interviews (CI) with N= 14 adult patients with pancreatic cancer from 
one of two US clinic sites to assess patient comprehension and usability of the 
electronic instrument. Results: Gastrointestinal (GI) symptoms (loss of appetite, 
early satiety, gas/bloating, constipation, diarrhea, nausea), pain and discomfort (in 
particular, in the abdomen and back), tiredness/low energy, weight loss and physical 
weakness, jaundice, and itching emerged as predominant concepts from the patient 
CE interviews. Patients commonly reported difficulty with activities of daily living, 
and noted physical (e.g., climbing stairs, walking, standing, carrying objects), work, 
social/relationship, emotional (e.g., depression, anxiety/fear), and sleep limitations. 
Patients also reported a negative impact on overall quality of life. Results from the 
CI indicate that patients had no comprehension problems for most items; however, 
minor revisions were made to the wording of a few items (e.g., early satiety, stomach 
pain, standing) to improve clarity. No concerns were raised about the usability of the 
electronic diary; patients reported that it was easy to use. ConClusions: Findings 
from this study support the content validity of the PC-SAF, a new PRO instrument 
to assess the key signs, symptoms, and impacts experienced by adult patients with 
pancreatic cancer.
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objeCtives: Although presence of depression and poor health-related quality of 
life (HRQol) lead the poor clinical outcomes in patients with COPD. However, little 
is known about the prevalence or risk factors for depressive symptoms in patients 
with chronic obstructive pulmonary disease (COPD) in India. Therefore, the current 
study was conducted to estimates rates and factors associated with depression and 
poor health-related quality of life(HRQol) in the COPD patients attending a tertiary 
care health facility in north India. Methods: A total of 126 patients (73.81% male) 
were enrolled using convenient sampling prospectively in this cross-sectional study. 
Eligible patients were assessed for socioeconomic status, anthropometric measures, 
COPD severity, dyspnea and health status using the Hindi version of St George’s 
Respiratory Questionnaire (SGRQ). COPD was classified according to GOLD stages 
based on forced expiratory volume in one second (FEV1) in 126 stable patients. 
Depression was examined by administering the nine-item Hindi version of Patient 
Health Questionnaire-9 (PHQ-9). Linear regression model was used to identify the 
risk factors for depression and poor quality of life. Cronbach alpha was calculated 
to assess internal consistency of PHQ-9 and SGRQ. Results: Among the patients 
ferently framed opt-out alternatives in discrete choice experiments. We hypoth-
esize that within the same experiment, when opt out alternatives are framed as a 
rejection of all the available alternatives, it is likely to have a detrimental impact 
on the performance of RRM model, while the performance of RUM model suf-
fers more when the opt out is framed as a respondent being indifferent between 
the alternatives on offer. Methods: We used two waves of data from a discrete 
choice experiment (N1 = 227; N2= 344); the first wave included an opt-out option 
implying a rejection of choice alternatives (i.e. none of these) while the second 
wave included an opt-out option implying a position of ‘indifference’ between the 
choice alternatives. We compared RUM and RRM models of different sophistica-
tions (e.g.; multinomial logit and mixed logit) in terms of parameter estimates, log 
likelihood and the Ben-Akiva and Swait test for non-nested models. Results: In 
line with hypotheses, RUM models performed significantly better (P< 0.01) than 
RRM models when opt–out alternative implied rejection of choice alternatives 
i.e. none of these. The RRM models performed significantly better (p< 0.01) than 
the RUM models when the opt-out alternative implied a position of ‘indifference’. 
RRM models had difficulty in handling the ‘none of these’ opt-out alternative 
while the RUM models had difficulty in handling the ‘indifference’ opt out alter-
native as was evident by the suspiciously large value of opt-out constant in the 
model parameter estimates for these cases. ConClusions: The framing of opt 
out alternatives influences the type of behavioral framework to be considered for 
modeling.
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objeCtives: The introduction of patient satisfaction metrics for pain manage-
ment as part of the Hospital Consumer Assessment of Healthcare Providers and 
Systems (HCAHPS) survey may impact decision making in postoperative pain man-
agement (POPM). The potential influence of patient satisfaction metrics, combined 
with evolving practice patterns that remain highly individualized to physicians and 
hospitals, creates a need to understand what treatment attributes influence physi-
cian selection of inpatient POPM strategies. Methods: This adaptive approach 
conjoint analysis was a self-administered online survey of surgeons that treat POPM. 
Treatment attributes were developed based on qualitative interviews with clinicians, 
peer-reviewed literature, and input from the sponsor. The conjoint consisted of 9 
attributes (patient mobility, adverse event profile, pain control, daily cost of pain 
medication, analgesic gaps, staff utilization, medication type, route of administra-
tion, and patient satisfaction), totaling 28 levels. When considering their answers, 
respondents were asked to think of a specific type of post-surgical patient. The study 
received central IRB approval. Results: A total of 288 surgeons [male = 88%; mean 
(SD) years in practice 19(9)] were included in the study. Surgeons were screened to 
ensure they performed inpatient surgeries resulting in a need to provide inpatient 
POPM. Surgical subspecialties included general surgeons who performed abdominal/
colorectal surgeries (n= 97), gynecologic surgeons (n= 95), and orthopedic surgeons 
(n= 96). When selecting POPM strategies, surgeons valued (strength of preference) 
patient satisfaction with pain management (15.3%), a patient’s ability to mobilize 
(14.9%); adverse event profile (14.6%), and pain control effectiveness (13.6%). There 
is variability in the utility rankings by specialty. ConClusions: When selecting a 
POPM strategy physicians consider a multitude of factors that go beyond the efficacy 
and safety profile of a solution. Patient satisfaction, which may be inclusive of but 
not limited to efficacy, will likely maintain or increase its influence on physician 
selection of POPM.
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objeCtives: The Hyperphagia Questionnaire (HQ) is a well-established, caregiver-
reported questionnaire that focuses on food-seeking behaviors common among 
individuals with Prader-Willi syndrome (PWS). The goal of this research was to 
develop and psychometrically evaluate a modified version of the HQ for use 
within PWS clinical trials. Methods: Following modification of the HQ based on 
industry and regulatory standards (e.g., Food and Drug Administration, 2009), the 
initial, 10-item version of the HQ for Clinical Trials (HQ-CT) was used in a phase 
2 trial with the resulting data analyzed to identify the optimal scoring approach 
and evaluate instrument psychometric properties. Next, further evaluation by 
clinical experts in PWS and regulatory authorities resulted in removal of an item 
that focused more on patient-caregiver interactions than direct observation of 
patient behavior. Qualitative interviews were then conducted with PWS caregivers 
to inform final refinements, provide additional support for content validity, and 
assess usability of the electronic (ePRO) version of the 9-item measure. Results: 
Initial modifications to the HQ reduced the recall period, optimized response 
scales, and limited item content to observable behaviors that have the potential 
to change during the course of a clinical trial. Psychometric evaluation supported 
the use of a single HQ-CT composite score as well as the questionnaire’s reliability 
and validity. The HQ-CT total score was also able to demonstrate improvements 
in hyperphagia-related behavior between treatment groups. Finally, qualita-
tive interviews with 6 caregivers supported the relevance and comprehensive-
ness of the content, item clarity, and the ePRO version of the HQ-CT’s ease of 
use. ConClusions: Qualitative and quantitative evidence provide support for 
use of the 9-item HQ-CT total score for the assessment of food-seeking behav-
iors in PWS clinical trials. The HQ-CT is currently being used in a phase 3 PWS 
study.
